Pulsed Field Ablation
17
7
9
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (17)
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
OPTION-EMEA Clinical Trial
PULSE PVC Registry: Multicenter Study on Focal Pulsed Field Ablation for Premature Ventricular Contractions
Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation
Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease
Atrial Remodeling After PFA Substrate Modification for Persistent AF (PeAF)
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
3-Dimensional Mapping System: The PULSTAR II Study
Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
Pulsed Field Ablation for Non-valvular Atrial Fibrillation After Left Atrial Appendage Occlusion
Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA
Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation
Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland
3D-Guided Pulsed Field Ablation for Paroxysmal AF
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation